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Abstract
The transepithelial potential difference (PD) of cystic fibrosis
(CF) airway epithelium is abnormally raised and the Cl- per-
meability is low. We studied the contribution of active Na' ab-
sorption to the PD and attempted to increase the Cl- permeability
of CF epithelia. Nasal epithelia from CF and control subjects
were mounted in Ussing chambers and were short-circuited. The
basal rate of Na' absorption was raised in CF polyps compared
with control tissues. Whereas beta agonists induced Cl- secretion
in normal and atopic epithelia, beta agonists further increased
the rate of Na' absorption in CF epithelia without inducing Cl-
secretion. This unusual effect is not due to an abnormal CF beta
receptor because similar effects were induced by forskolin, and
because cAMP production was similar in normal and CF epi-
thelia. We conclude that CF airway epithelia absorb Na' at an
accelerated rate. The abnormal response to beta agonists may
reflect a primary abnormality in a cAMP-modulated path, or a
normal cAMP-modulated process in a Cl- impermeable epithe-
lial cell.
Introduction
Ion transport by airway epithelia from subjects with cystic fibrosis
(CF)' is abnormal. Previously we reported that the transepithelial
electric potential difference (PD) was raised across CF respiratory
epithelia and speculated that this abnormality might reflect an
increased rate of Na' absorption (1). Subsequently, we found
that Cl- permeability was abnormally low and noted that this
defect might contribute to the raised PD in respiratory epithelia
(2, 3). Quinton (4) has reported decreased chloride permeability
ofsweat ductal epithelium and also suggested that Cl- imperme-
ability is the primary defect that characterizes the CF epithelial
dysfunction (5). Either raised Na' absorption or decreased Cl-
secretion could account for the lower water content of CF pul-
monary secretions and airways surface liquid (6-8).
This work was performed during Dr. Boucher's tenure as an Established
Investigator of the American Heart Association.
Address correspondence to Dr. Boucher, Div. ofPulmonary Diseaes,
724 Burnett-Womack Bldg. 229H, University ofNorth Carolina, Chapel
Hill, NC 27514.
Received for publication 7 November 1985 and in revisedform 19
June 1986.
1. Abbreviations used in this paper: CF, cystic fibrosis; G, conductance;
Isc, short-circuit current; M, mucosal; PD, potential difference; PGEI,
prostaglandin El; S, submucosal.
The present study was initiated with two goals: (a) to com-
pare the rate ofNa' absorption across excised and short-circuited
airway epithelia from a large number of CF patients, with that
oftissue obtained from normal and disease control subjects; and
(b) to test in CF respiratory epithelia the effects of agents, e.g.,
beta adrenergic agonists, that stimulate chloride secretion in
normal respiratory epithelia (9-11). Because these agents are
thought to work by changing cell cAMP concentrations (10-
1 1), we also investigated the effects of beta adrenergic agonists
on the rate of cAMP production in tissue biopsies of CF and
normal nasal epithelia. Excised nasal epithelium was studied
because these tissues are frequently available, relatively free of
infection, and exhibit defects expressed in lower airways (1).
Methods
CF subjects. All patients with cystic fibrosis (age range, 6-27 yr; mean
age, 13.1±5.0 yr; 14 males, 13 females) were characterized by traditional
clinical criteria and raised sweat C1- values. 27 subjects, comprising our
entire experience, were used for the population comparisons of short-
circuit current (Isc). Tissues from 25 subjects were used for isotope flux
studies to quantitate baseline ion transport activities. Tissues from 14
patients were used for studies of adrenergic agents. Only two of these 14
patients had received oral methyl-xanthines or inhaled beta agonists in
the month before surgery. 6 of these 14 patients had received nasal
steroids; each patient discontinued therapy at least 2 wk before surgery.
Control subjects. Control subjects underwent turbinate reductions
for nasal reconstruction or sleep apnea. 53 subjects (age range, 9-62 yr;
mean age, 31.2±12.6 yr, 29 males, 24 females), accounting for all normal
tissues studied for the previous 40 mo in our laboratory, were used for
population studies of Isc. Tissues from 41 subjects were employed in the
assessment of baseline ion transport activities utilizing isotope flux mea-
surements. The tissues from 20 normal subjects were used for studies of
adrenergic agents. No control subjects were receiving medication (oral
or nasal) before surgery.
Atopic subjects. The 18 patients (age range, 10-68 yr; mean age,
32.1±13.8 yrs; 11 males, 7 females) were characterized by seasonal rhi-
nitis, a raised concentration of circulating eosinophils, and nasal polyps.
All 18 subjects were used for population studies of Isc. Tissues from nine
subjects were employed in the studies ofbaseline ion transport activities.
Most patients were treated with topical nasal steroids, but therapy was
usually discontinued 2 wk before the operation. Two subjects were taking
systemic steroids at the time of study and two were taking methyl-xan-
thines. The six patients that were used for studies of adrenergic agents
were receiving no adrenergic agents.
Operative techniques. All patients that had polypectomies and more
than half of the patients that underwent reconstructive surgery were
exposed to general anesthesia. Topical anesthetic was not administered
before excision of any tissue.
Tissue preparation, bioelectric measurements, and measurement of
solute permeabilities. All studies were performed in a laboratory adjacent
to the operating room and were often performed by the authors at in-
stitutions other than the University of North Carolina (see Acknowl-
edgments). Freshly excised tissue was carried directly to a laboratory,
dissected free ofsubmucosal tissue, and mounted in Ussing flux chambers
(surface area, 0.26 or 0.53 cm-2) within 15 min of excision (3, 9). The
tissues were dissected and maintained in Ussing chambers in a Krebs-
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bicarbonate Ringer solution (KBR) with a composition of(in millimoles
per liter): 140 Na', 120 C1-, 5.2 K+, 25 HCO-, 2.4 HPO-, 0.4
H2PO4, 1.2 Mg++, 1.1 Ca", 5.6 glucose. The tissues were continuously
short-circuited (transepithelial PD = 0 mV) except for a 45-s interval
every 15 min when the open circuit potential was recorded. Conductance
(G) was calculated from Ohm's law.
Unidirectional solute permeabilities (22Na, -6CI-, and '4C-mannitol,
all obtained from New England Nuclear, Boston, MA) were measured
in the mucosal (M) to submucosal (S) direction and in the S -- M di-
rection in separate tissues. Samples for radiocounting were obtained every
15 min. Gamma and beta scintillation counting and the calculation of
solute permeabilities were performed as described previously (3) and
reflect steady-state values. When more than one preparation per patient
specimen was obtained (range, 1-4), tissues were generally allocated to
opposite flux directions. However, we could not routinely measure fluxes
across conductance matched preparations from the same patient specimen
because of the frequency of single preparations per specimen and the
occurrence of a G disparity of> 10% for two preparations from the same
patient specimen. Consequently, we matched the G and Isc (within 8%)
cumulatively as tissues were obtained in each flux direction (M -- S,
S -. M) for specimens from each group of patients. The flux intervals
between 45 and 75 min, before any drug addition, were used for the
estimates of baseline parameters. For the assessment of the effects of
isoproterenol on solute fluxes across nasal epithelia, after steady state
measurements were made (45-75 min), tissues were exposed to indo-
methacin (10-6 M/liter in both bathing solutions) for 60 min followed
bytheaddition ofisoproterenol (10-4 M/liter) for 7 5 min. Amiloride (10-4
M/liter) was then added to the mucosal solution.
Similar protocols were generally employed for studies ofthe bioelectric
effects of other drugs that may alter cell cAMP concentrations (10, 11).
75 min after mounting, the tissues were usually pretreated with indo-
methacin (10' M), a maneuver designed to minimize baseline C1- per-
meability (12, 13). After 60-min exposure to indomethacin, the tissues
were exposed to a second drug; 60 or 75 min later a third agent was
added. One protocol (see Fig. 6) required addition of a fourth drug. All
drugs except amiloride were added to both (mucosal and submucosal)
bathing solutions. Amiloride was added only to the mucosal solution.
Except for indomethacin and bumetanide, the concentration of each
drug was increased in log steps from 10-9 M to a final concentration of
101 M (prostaglandin El; PGEI), 10-1 M (forskolin), or 10-4 M (iso-
proterenol, amiloride).
All tissues were fixed in the flux chamber after study for histologic
characterization (3).
Measurement ofcAMP. Small (<1 mg) mucosal biopsies were ob-
tained by sharp dissection from excised tissues and maintained in KBR
at 370C under an atmosphere of 95% 02-5% CO2. For time course
studies, biopsies were exposed to maximal effective concentrations of
isoproterenol (10-4 M) for periods of 2, 5, 10, 20, and 60 min. For dose-
effect studies, biopsies were exposed to a beta agonist (isoproterenol,
10-9-10' M), isoproterenol (10-4 M) and sotalol (10-4 M), or a direct
stimulator of adenylate cyclase, forskolin (14), (10-7-10-1 M) for 2 min
at 370C. cAMP content ofa TCA (10%) extract ofthe tissue was measured
by radioimmunossay as described by Steiner et al. (15). The TCA-pre-
cipitated pellet was solubilized in 200 Al of a 0.05% sodium dodecyl
sulfate (SDS) and 0.05% NaOH solution, and protein content was mea-
sured by the method of Bradford (16). Each exposure of tissue from a
patient to a drug was carried out in triplicate and the results for each
drug concentration were averaged. The recovery of added radiolabeled
cAMP exceeded 90%. All cAMP levels were expressed as picomolars per
milligram protein.
Drugs and solutions. KBR was the standard solution (9). Indometh-
acin, PGE,, and isoproterenol HC1 were obtained from Sigma Chemical
Co., St. Louis, MO; forskolin was obtained from Calbiochem-Behring
Corp., La Jolla, CA, and bumetanide was from Leo Pharmaceu-
ticals, Copenhagen, Denmark. Amiloride was a gift of Merck, Inc.,
Rahway, NJ.
Data analysis. We discarded data from specimens with G>25
mS * cm-2. This was comprised of 20% ofCF specimens, 28% of atopic
specimens, and 31% of specimens from normal subjects. This selection
criterion reflects two considerations. Fit, no tissue with aG that exceeded
25 mS * cm-2 exhibited a PD that exceeded 2 mV. Because 2 mV rep-
resents 10-15% or less of the in vivo values for PDs in CF or normal
subjects (1), these specimens are unlikely to reflect in situ function. Sec-
ond, as G of the tissue approaches G of the bathing solution (-40
mS * cm-2), small errors in bathing solution fluid resistance compensation
will induce significant errors in measuring Isc and G. The transport rate
of tissues from different populations (Isc) that met this criterion was
compared by averaging the maximal Isc under basal conditions that was
sustained for 15 min of all tissues from each patient. Because Isc values
for subjects within a group were not normally distributed, nor were group
variances equal, the differences between groups were compared by the
Wilcoxon rank sum test.
For comparisons of baseline unidirectional and net solute perme-
abilities and bioelectric properties, the mean steady state values for the
45-75 min intervals, before drug exposure, were employed. Ifmore than
one specimen was obtained from a subject in a flux direction, the values
were averaged to provide a single estimate per subject. Because the dif-
ferences in G and Isc between the flux directions were <8% in all groups,
and were not significantly different, these values were meaned for pre-
sentation (Tables I and II). In contrast to the data for Isc, the values of
G and the unidirectional fluxes were normally distributed for all groups
(Shapiro-Wilks Test of Normality). Therefore, values for unidirectional
fluxes were compared within each group with t tests for independent
means. Values for G and unidirectional solute permeabilities for different
groups were compared with t tests for independent means. Comparison
of net fluxes (JNe+) for different groups was performed with a t test
for independent means employing data only from patients where sufficient
tissue was obtained to allocate a specimen to each flux direction (17 CF
patients, 11 normal subjects, 8 atopic subjects). Drug-induced changes
in unidirectional solute permeabilities and bioelectric properties were
compared with paired t tests.
Table I. Baseline Bioelectric Properties and Solute Flows
Across Excised and Short-circuited Nasal Epithelium
From Normal, Cystic Fibrosis (CF), and Atopic Subjects*
Bioelectric properties Normal CF Atopic
mean±SEM mean±SEM mean±SEM
PD (my) 4.6±.4 10.9±1.1* 5.6±1.2
Isc (I4 - cm-2) 67.4±3.5 150.0±12.2* 86.5±13.2
G (mS cm-2) 15.4±0.6 14.0±1.0 15.5±1.4
Ion fluxes
(J, eq cm-2' -h')
JNM. 7.34±.46 10.01±.69* 8.12±.76
JSNV+ 5.02±.28 4.68±.61 6.16±.56
JNP:- 2.32±.5 1 § 5.33±.95§" 1.96±.921
JaS 7.34±.39 5.31±.40t 8.20±.79
JaM- 7.12±.31 4.79±.61f 8.11±.92
Ja- 0.22±.49 0.52±.70 0.09±1.23
Mannitol permeability
(P. Xlt-1cm s-')
PMa 35.4±3.2 33.0±3.8 38.7±10.6
PSM 35.8±5.1 30.0±4.3 39.9±7.5
* The mean data reflect the contribution of patients as follows: Normal, MS flux
direction, 27 patient specimens, 38 preparations; SM 29 patient specimens, 39
preparations; 41 patients in total. CF, MS, 22 patient specimens, 34 prepara-
tions; SM, 18 patient specimens, 26 preparations; 25 patients in total. Atopic,
MS, 8 patient specimens, eight preparations; SM, nine patient specimens, nine
preparations; nine patients in total. The comparison for JN. employed data for
17 CF patients, 11 normal subjects, and eight atopic subjects.
* Different from normal or atopic (P < 0.01).
§ Different from zero (P < 0.001).
1" Different from normal or atopic (P < 0.05).
¶ Different from zero (P < 0.05).
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Table II. Bioelectric Properties and Solute Flows at Short-circuit Conditions Across Excised Nasal Epithelium From
Normal and Cystic Fibrosis Subjects That Were Exposed to Indomethacin (10-6 M) and Isoproterenol (10-4 M)
Normal (n = 9) Cystic fibrosis (n =6)
Control Indomethacin Isoproterenol Control Indomethacin Isoproterenol
Bioelectric properties
Isc (M cm-2) 65.8±9.3* 60.1±6.9 80.6±9.4¶ 157.3±24.8 139.5±19.9 176.4±29.81
G (mS cmn2) 14.0±0.7 13.5±0.7 15.8±0.91 13.2±1.7 13.4±1.2 13.8±1.3
Solute flows J(,ueq. cm2' h-')
JN"TS+ 6.58±0.65* 6.63±0.70 6.48±0.83 10.39±1.39 10.03±1.03" 11.43±1.371
JSNK+ 4.38±0.50 4.35±0.48 4.65±0.52 3.89±0.83 4.13±0.80 4.60±0.70
JNM+ 2.20±0.82f 2.28±0.85f 1.93±0.98 6.50±1.62§ 5.90±1.30§ 6.83±1.53§
JaS- 7.13±0.93* 7.04±0.89 7.14±0.95 5.17±0.82 4.99±0.74 5.15±0.85
JaM 7.31±0.49* 7.28±0.51 8.74±0.631 4.12±0.86 4.67±0.87 4.84±0.69
Jag -0.18±1.05 -0.24±1.03 -1.60±1.13 1.05±1.19 0.32±1.14 0.31±1.09
Mannitol permeability (P. XI07 cm - s-') 37.1±4.6 35.8±4.4 36.1±5.1 32.0±5.3 30.1±3.4 36.6±3.6
-Jt, secretion. * Different than CF (P < 0.05). t Different from zero (P < 0.05). § Different from zero (P < 0.005). 11 Different than control
value (P < 0.05). ¶ Different from Indomethacin value (P < 0.05).
Results
The frequency distribution of mean Isc of tissues excised for
each subject from CF, allergic, and control patients is shown in
Fig. 1. Although considerable overlap in Isc exists, CF tissues
exhibit a significantly greater Isc than do tissues from normal
(P < 0.001) or atopic patients (P < 0.001). No significant dif-
ference in Isc was noted between normal and allergic patients.
As previously reported, the superficial epithelium of tissues from
each group was characterized by -80% ciliated cells (3).
The baseline bioelectric parameters and solute permeabilities
for tissues ofnormal, CF, and atopic subjects are shown in Table
I. The values for normal subjects (n = 41 subjects) for all pa-
rameters are similar to those reported previously (3). Net Na'
absorption is the major active ion flow across the excised and
short-circuited normal nasal epithelium and accounts for >90%
of the measured Isc. The Ca- fluxes are equal. The sum of the
passive ion flows for Nae and Ca- (partial ionic conductances)
was -80% ofthe measured G. The disparity between the partial
ionic conductances and G may represent the contribution of
unmeasured solution ions (e.g., HCO3), the conductances as-
sociated with the active Na' path (apical GN.+, basolateral GK
[17, 18]), or both. Although there is a trend for Isc to be slightly
increased in atopic polyp epithelia, no systematic differences
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Figure 1. Distribution of short-
circuit current of tissues excised
from cystic fibrosis (A), allergic
(B), and normal subjects (C).
The average number of tissues
studied per patient was 3.0± 1.0
for CF, 2.1±0.5 for allergic,
and 1.8±0.6 for normal sub-
jects.
between any baseline parameters ofatopic polyp (n = 8 subjects)
and normal epithelia were detected.
CF polyp epithelium could be distinguished from normal or
atopic epithelia by the higher resting current (Isc) and PD. Ex-
amination ofthe unidirectional fluxes reveals that the increased
Isc of CF tissues reflects a greater rate of net Na' absorption.
This increase in net Nae absorption principally reflects an in-
creased flux in the active (JN+) direction. Unidirectional C1-
fluxes across CF epithelia were smaller than measured in normal
or atopic tissues. No net CQ- translocation was detected. Despite
the smaller Cl- fluxes, G in CF tissues was not significantly
smaller in CF than normal or atopic tissues. The partial ionic
conductances for Na' and C1- (JQs', J's) accounted for -70%
of G. We do not know whether the greater disparity between
the sum of the partial ionic conductances for Na' and Ct- and
G in CF tissues reflects the contribution ofan active component
to G, e.g., associated with the greater Na+ transport rate, or an
unmeasured ion. Mannitol permeability coefficients, a marker
of paracellular permeability (19, 20), were not different for any
of the three groups.
The response of short-circuit current to sequential exposure
to indomethacin, isoproterenol, and amiloride is shown in Fig.
2. Indomethacin exerted little effect on Isc (or PD or G; see
Table II) of normal turbinate but isoproterenol (10- M) initially
raised Isc and G. The increase in current decreased slowly over
75 min, and amiloride then further reduced Isc by '40%. The
response ofatopic polyp tissues was similar to normal turbinate:
isoproterenol raised Isc by 27.5±4.1 ,uA * cm-2 and raised G by
2.9±1.0 mS cm2. Isc was subsequently decreased by amiloride
(10-4 M) by 31.6±3.2% (n = 3). The pattern of response ofCF
epithelia to isoproterenol exhibited three distinct differences from
normal or atopic tissues. First, the isoproterenol-induced increase
in Isc in CF tissues was slower to develop and more sustained.
Second, G did not significantly change (+0.4±0.5 mS cm-2,
Table II). Third, during exposure to isoproterenol the Isc could
be completely abolished by amiloride. A similar response was
noted for three CF nasal tissues that were not indomethacin
pretreated and for excised bronchial epithelium from two CF
patients.











0 30 60 90 120 150 180 210 240
TIME (min)
Figure 2. Effect of sequential addition of indomethacin (10-6 M), iso-
proterenol (10-' M), and amiloride (10-' M) on short-circuit current
of nasal tissues excised from CF (i) and normal (.) subjects. Each
point is the mean of 12 CF or 12 normal tissues. Bars represent SEM.
Similar responses in both CF and normal tissues were ob-
served with lower concentrations of isoproterenol (106 M/liter).
Responses of both CF and control tissues to isoproterenol were
blocked by pretreatment with sotalol (l1-0 M). Exposure to ve-
hicles alone was not associated with significant changes in CF
polyp or normal turbinate Isc.
Analysis of solute and ion permeabilities for these tissues
confirmed that isoproterenol induced qualitatively different ef-
fects on ion flow across CF and normal tissues. In the basal state,
or after indomethacin, net Na+ absorption accounted for >90%
of the Isc of both CF and normal tissue (Table II). Net Na+
absorption was two- to threefold greater in CF tissues. Isopro-
terenol induced a significant increase in unidirectional secretory
(S -- M) Cl- flow in normal tissues but no significant change
in Na+ translocation or mannitol permeability (P, X lI0-
cm * s'). In contrast, isoproterenol raised the rate of Na+ flow
in the absorptive (M -- S) direction but did not affect C1- flow
across CF tissues.
Amiloride pretreatment of normal tissues may increase the
C1- secretory response to beta agonists in part by increasing the
electrical gradient that favors chloride exit from the cell (apical
membrane hyperpolarization). The magnitude of the isoproter-
enol-induced increase in Isc after amiloride pretreatment, which
reflects C1- secretion, is likely to be influenced by this process
(Fig. 3). A similar response was noted in atopic tissues (A Isc
induced by isoproterenol after amiloride = 37.1±4 ,A cm-2, n
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Figure 3. Effect ofsequential addition ofindomethacin (106 M), amilo-
ride (10- M), and isoproterenol (l0-4 M) on short-circuit current of
nasal tissues excised from CF (a) and normal (-) subjects. Each point
is the mean of six CF or four normal tissues. Bars represent SEM.
= 4). Since isoproterenol did not stimulate short-circuit current
ofCF tissues pretreated with amiloride, it appears that the lower
Cl- permeability of the CF epithelium cannot be reversed by
beta agents. These results also support the notion that isopro-
terenol selectively raises the rate ofNa' absorption in CF tissue.
Because beta adrenergic agents induced a Na' flux response
in CF tissues, it seemed likely that dysfunction ofCF tissue was
not linked to a defect in beta receptor function. We tested this
possibility more rigorously by two approaches. First, tissues were
exposed to agents that induce a Cl- secretion in normal tissues
that is independent of beta receptor stimulation. For example,
PGEI (10-6 M), an agent which raises apical chloride conduc-
tance in non-CF airway epithelia (21), increased the Isc of nor-
mal, atopic and CF tissues by 22±8.4% (n = 4), 34±7.1% (n
= 3), and 31±5.9% (n = 4), respectively. The entire Isc (100%)
ofCF tissues (n = 4) was sensitive to amiloride, whereas Isc fell
by only 38±5.9% (n = 4) and 35±6.8% (n = 3) in normal and
atopic tissues, respectively. Consequently, interaction of another
agonist with a separate population of receptors, i.e., the PGEI
receptor, mediates the same change in Na' transport in CF tissues
as does activation of the beta receptor. Moreover, exposure of
tissues to forskolin, a direct stimulator of adenylate cyclase ac-
tivity, also induced the same pattern of response by CF and
normal tissues (Fig. 4).
We also measured intracellular concentrations of cAMP
as an index ofbeta receptor activation. The time course ofcAMP
concentration in biopsy specimens after exposure to a maximal
concentration of isoproterenol (10-' M) is shown in Fig. 5 A.
Basal concentrations are similar to those reported by others (22).
No differences between CF and normal in the peak concentration
or time course were noted. Log dose-effect relationships for the
increase in tissue cAMP induced by a 2-min exposure to iso-
proterenol were also explored (Fig. 5 B). The maximal increases
in cAMP for CF and control epithelia were again similar at l0-4
M isoproterenol (16.8±9.4 pM/mg protein, n = 5; 18.4±11.1
pM/mg protein, n = 4), respectively. The concentration of iso-
proterenol that induced the half-maximal increase in cAMP
(EC50) was similar for CF and normal epithelia: 5 X lI0-; 8
X I0-7 M, respectively. Sotalol (l0-4 M) blocked the increase
in cAMP induced by isoproterenol. Forskolin (l0-_-l0-4 M)
induced larger increases in cAMP in CF and normal tissues. The
maximal concentration accumulated after forskolin was similar
for CF and normal tissues: 39.9±16.1 pM/mg protein, n = 4;
and 37.3±11.5 pM/mg protein, n = 4, respectively. The EC50s
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Figure 4. Effect of sequential addition of indomethacin (10' M), for-
skolin (10'- M), and amiloride (l0-' M) on short-circuit current of
nasal tissues excised from CF (m) and normal (.) subjects. Each point
is the mean of four CF or three normal tissues. Bars represent SEM.
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Figure 5. (A) Time course ofcAMP concentration in biopsies from CF
(n) and normal nasal specimens (e), exposed to maximal (10-' M)
concentration of isoproterenol. Each point is the mean of four tissues;
bars depict SEM. (B) Dose-effect relationship between log concentra-
tion of isoproterenol and cAMP concentrations in biopsies from CF
(-) and normal nasal specimens (.). All specimens were exposed to
isoproterenol for 2 min. Each point reflects the mean of four normal
and five CF patients, bars depict SEM.
for forskolin were also similar forCF and normal tissues: 2 X 104
M/liter; 9 X lo- M/liter, respectively. Biopsies with epithelium
removed produced unmeasurable quantities of cAMP in re-
sponse to isoproterenol or forskolin.
Finally, we attempted to reduce cell Cl- permeability of nor-
mal tissues by pretreatment with indomethacin and bumetanide,
a loop diuretic that inhibits coupled Na/Cl movement across
the basolateral membrane and consequently inhibits the capacity
for Cl- secretion (23; and Fig. 6). Bumetanide appeared to reduce
the C1- secretory capacity of normal tissue because the effects
of isoproterenol on Isc were blunted and the residual Isc in the
presence of amiloride, which reflects the induction of C1- secre-
tion, was smaller (compare Fig. 2 and Fig. 6). This effect was
probably not accompanied by a change in resting Na' absorption
because Isc was constant during the period of exposure to in-
domethacin and bumetanide (120-185 min). Furthermore, bu-
metanide did not influence the effect of isoproterenol on the Isc
ofCF tissue, again suggesting that the response of CF tissues to
isoproterenol does not involve a Cl- pathway.
Discussion
Like our previous report (3), unidirectional Cl- fluxes across
freshly excised and short-circuited CF polyp epithelia were
TIME (min)
Figure 6. Effect of sequential addition of indomethacin (10-6 M), bu-
metanide (10-4 M), isoproterenol (10-4 M), and amiloride (10-4 M) on
short-circuit current of nasal tissues excised from CF (v) and normal
(X) subjects. Each point is the mean of four CF or five normal tissues.
Bars represent SEM.
smaller than C1- fluxes measured across nasal epithelium from
normal subjects (Table I). The smaller CV- fluxes appear not to
reflect differences in tissue architecture (polypoid morphology)
nor chronic inflammation because polyps excised from allergic
patients do not share this feature. The permeability of a probe
of the paracellular path, ['4C]mannitol (19, 20), was not different
for the three subject groups. Thus, it is probable that the de-
creased C1 permeability of the CF polyp epithelium is located
in a cellular path. However, the data shown in Fig. i and Table
I differ in two important respects from those reported previously
(3). First, in the present study we observed that CF nasal epithelia
absorb Na' under short-circuit conditions at a rate approximately
twofold greater than nasal epithelia of normal or atopic individ-
uals. Second, the transepithelial slope conductance (G) of CF
tissues in this study is equal to rather than smaller than the G
of the normal or disease control tissues.
The apparent discrepancies between the two studies reflect
the difficulties in comparing baseline functions ofepithelia freshly
excised from human subjects. We have attempted to identify
and analyze variables that may specifically contribute to the dif-
ferences in Na' transport rate and G noted in these studies.
Certain variables are relatively easy to identify and quantitate,
e.g., patient age, medication history, and distribution ofcell types
in the resected specimen. These variables did not differ in the
two studies, nor as discussed in the previous report, are they
likely to account for the differences in function noted in the CF
epithelia (3). Consequently, it may not be possible to identify
the specific variable(s) that account for the discrepency between
this study and our earlier, smaller sample. However, two other
variables may be pertinent to the specific differences between
the two studies but are more difficult to quantitate.
First, the interval between operative excision and mounting
in a well-gassed perfusion chamber represents a period of relative
tissue hypoxia that likely impairs tissue function. Because of
increased experience, this interval routinely decreased by 50%
in this as compared with our previous study. Recently, we have
reported that hypoxia or metabolic inhibitors rapidly reduce Isc,
G, active Na' absorption, and unidirectional ClP fluxes in re-
spiratory epithelia (24). These findings parallel studies by others
where hypoxia has been shown to reduce Isc, apical membrane
Na' conductance (GNa+), transepithelial G, and Na' absorption
(25). Therefore, it is possible that the increased Isc and Na'
absorption ofCF tissues in the present study reflect better pres-
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ervation of function ofthe Na' transport path due to more rapid
tissue mounting. It is also possible that the increased G noted
in the present study reflects in part an increase in cell G associated
with the greater rate ofNa' transport (increased apical GNa+ and
basolateral GK). The observation from a recent microelectrode
study that the near-instantaneous change in G induced by amil-
oride blockade of active Na' absorption was threefold greater
in CF than normal epithelia (A G = 3.1 mS * cm-2 for CF; G
= 0.8 mS * cm-2 for normal tissues) supports this notion (26).
Second, excised specimens can be physically damaged during
acquisition and during clamping in a flux chamber. The PDs of
excised CF and normal tissues are proportionately lower than
those measured in vivo (3). We do not know the permeability
of the paracellular path to mannitol in situ. However, the rela-
tively high Pm.,,it., values (30-40 X lo- cm - s-') measured in
nasal epithelia as compared with excised canine or human bron-
chi (15-20 X lo- cm s-') (9, 24), raise the possibility that
physical damage may have occurred to the specimens during
the operative excision and/or mounting procedure. Such damage
would create nonselective leaks in the epithelial barrier that
would serve to partially shunt the transepithelial PD. The ad-
dition of a leak path to the native tissue passive permeability
paths complicates any comparison of G for excised tissues.
However, the mannitol permeabilities in the present study were
not significantly different from those reported previously (3),
making it unlikely that damage alone can account for the in-
creased G noted in the CF tissues in this series. Note that a
nonspecific leak adds a component to unidirectional ion fluxes.
However, the net ion fluxes measured under equilibrium con-
ditions and their associated short-circuit current, Isc, are not
systematically altered by the leak component added to the uni-
directional fluxes, Indeed, the rate of net Na' absorption across
either CF or control tissues was not related to the magnitude of
the leak component, i.e., the difference between JNS+ vs. Na+
was independent of Pmannitol over a wide range.
In addition to the experimental variables encountered in
these studies, there must be some selection criteria employed
for inclusion of tissUes for data analysis. We elected to use G as
a criterion for selecting tissues on the basis ofprevious precedent
established by a number of studies of respiratory epithelia (9,
10, 23, 27). The specific limits for G (<25 mS * cm2) were se-
lected as described in Methods (Data analysis). Because CF polyp
G may be expected to be low secondary to a reduced CF- per-
meability, a bias might have been introduced into our data anal-
ysis by virtue of the selection of conductance as our criterion.
However, the number of tissues excluded by this criterion was
similar in each group (ranging from 20% for CF to 31% for
normals), making the potential contribution of this bias to our
results probably small.
Based on the above analysis, certain conclusions about basal
function of freshly excised CF epithelia as compared with normal
or disease control tissues appear justified. First, the absolute rate
ofNa' absorption is increased. The rate ofNa' transport cannot
be overestimated consequent to any of the variables analyzed
above. Whereas these studies do not identify the mechanism(s)
involved in raising the rate ofNa' absorption across CF epithelia,
recent microelectrode studies indicate that the increased rate
does not reflect simple changes in the electrical driving force for
Na' across the apical membrane consequent to reduced CF-
permeability (26). Indeed, the magnitude ofthe apical membrane
PD in CF is smaller (-15 mV) than for normal tissues (-30
mV). Second, the problem of tissue damage may generate suf-
ficient variability to make it difficult to reach firm conclusions
about differences in G. However, it appears probable that the
absolute G ofCF tissues may closely approximate that ofnormal
tissues but the distribution ofthe total conductance between the
Na' conductance and the Cl- conductance differs (26).
The responses to isoproterenol also identify a clear difference
in the nature of electrolyte transport by CF airway epithelia.
Isoproterenol raised Isc of epithelia from each population of
subjects. Such a response, however, could reflect either induction
(or an increase) of CF- secretion or increased Na' absorption in
respiratory epithelia. Our experiments show that isoproterenol
increased Cl- secretion in normal nasal epithelia. First, the in-
crease in Isc (Fig. 2), was accompanied by an increase of CF-
flux in the secretory direction without a change in the magnitude
of Na' absorption (Table II). Second, amiloride pretreatment,
which blocks Na' absorption and inhibits basal Isc, actually en-
hanced the Isc response to isoproterenol (Fig. 3). Third, pre-
treatment with an inhibitor ofCl- secretion, bumetanide, blocked
the response to isoproterenol (Fig. 6). Accordingly, although the
magnitude of Cl- secretion in response to adrenergic stimulation
is smaller in nasal epithelium than in some other proximal airway
epithelia (10, 1 1), the pattern of the response is typical.
In contrast, the increased Isc of CF tissues induced by iso-
proterenol (Fig. 2) reflects an increase in the rate of Na' ab-
sorption. The observation that the entire Isc after isoproterenol
stimulation was sensitive to amiloride (Fig. 2) provided the first
clue that isoproterenol increased the rate ofNa' absorption rather
than induced CF- secretion in CF tissue. The observations that
pretreatment with amiloride (Fig. 3) but not bumetanide (Fig.
6) completely abolished the response ofCF tissues to isoproter-
enol is in agreement with this notion. The most direct evidence,
however, comes from analysis of flux data, which show that
isoproterenol increased the rate of Na' flux in the absorptive
direction (JQ+) but induced no change in unidirection CF- flows
(Table II).
It has been proposed that the interaction between beta re-
ceptor and adenylate cyclase and the production of cAMP is
abnormal in CF (28-31). Our data suggest that the basis of the
different response noted in CF respiratory epithelia does not lie
in an abnormality in this receptor-enzyme system. CF tissues
respond to beta agonists, indicating that an agonist-receptor in-
teraction occurred, but the nature of the response is different.
Moreover, stimulation ofadenylate cyclase by different receptors,
e.g., PGEI receptors, or direct stimulation of adenylate cyclase
itselfby forskolin (Fig. 4), induces the same pattern of response
in CF tissues, suggesting that the major ion transport defect is
not attributable to an abnormality in this system. Finally, the
increase in cAMP production induced by isoproterenol or for-
skolin was similar in CF and control tissues. These results suggest
that adenylate cyclase function is comparable in epithelia from
both groups and is coupled to functional beta receptors. Because
the quantities of cAMP induced by isoproterenol or forskolin
in normal tissue are not the same but the maximal bioelectric
responses are comparable, differences between the responses be-
tween CF and normals probably cannot be accounted for by
differences in the cell concentration of "second" messenger.
Consequently, it appears that the abnormal response ofCF tissues
reflects a dysfunction ofa late process "distal" (to the production
ofcAMP) in the cAMP stimulatory pathway of the epithelial cell.
Our findings vary somewhat with those of Sato (32) in the
sweat gland acinus. As did we, Sato found that tissue cAMP
accumulation was similar in CF and normal tissues after iso-
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proterenol exposure. The functional difference described between
CF and normal sweat gland acinii exposed to beta agonists was
increased Cl- secretion in normal as compared with no response
in CF tissues. In contrast, we noted responses in both normal
and CF epithelia but a qualitative difference in the nature ofthe
response.
A single defect, e.g., reduced chloride permeability, may ac-
count for the dysfunction in the CF sweat duct (4). However,
the present study has shown that the ion transport dysfunction
in CF airways is more complicated. In addition to lower CF-
permeability, CF airway tissue is characterized by an abnormally
raised resting rate ofNa+ absorption and a qualitatively different
response to beta stimulation. Because ofthe absence of satisfac-
tory Cl- channel blockers, we at present cannot distinguish be-
tween the possibilities that all the defects in CF airway epithelia
reflect (a) the consequence of chronic reduction of cell Cl- per-
meability or (b) an abnormality in a cAMP dependent regulatory
system.
In conclusion, our data indicate that excised and short-cir-
cuited CF nasal epithelia exhibit a raised rate ofNa' absorption
that contributes to the raised PD characteristic ofairway epithelia
in this disease. Further, the rate of Na' absorption is increased
by exposure to beta agonists, a response different from normal
tissues or tissues from disease controls. A preliminary report
(33) indicates that the rate of Na' absorption across the nasal
epithelium under open circuited conditions is also increased.
Thus, it can be speculated that an increased rate ofNa' absorp-
tion, coupled with fluid movement, may contribute to the relative
dehydration of airway secretions that characterizes the CF lung
disease (6, 7).
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